IKT icon

Inhibikase Therapeutics
IKT

Overview Fund Activity

25 hedge funds and large institutions have $6.85M invested in Inhibikase Therapeutics in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+4
Holders Change %
+19.05%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$296K
2
ACM
2
ACT Capital Management
Pennsylvania
$1.58M
3
State Street
3
State Street
Massachusetts
$84K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$116K
5
Northern Trust
5
Northern Trust
Illinois
$42K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
M
2
Murchinson
Ontario, Canada
$327K
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
Envestnet Asset Management
4
Envestnet Asset Management
Illinois
$0
5
WAM
5
Warberg Asset Management
Illinois
$18K
Name Holding Trade Value Shares
Change 		Shares
Change %
Envestnet Asset Management
26
Envestnet Asset Management
Illinois
– -$21K -1,831 Closed
Rockefeller Capital Management
27
Rockefeller Capital Management
New York
– -$2K -250 Closed
1
2